• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ADVANTAGE FIT SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ADVANTAGE FIT SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number M0068502110
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fatigue (1849); Micturition Urgency (1871); Pain (1994); Urinary Retention (2119); Urinary Tract Infection (2120); Burning Sensation (2146); Prolapse (2475); Urinary Incontinence (4572)
Event Date 09/01/2015
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that an advantage fit device was implanted into the patient during a procedure performed on (b)(6) 2012 for the treatment of stress urinary incontinence and detrusor overactivity.The patient had initially a good response after the procedure but she came back in 2015 where urodynamics showed detrusor over activity.She went into the believe study and was then given with mirabegron.She then developed chronic fatigue syndrome and had some symptoms of worsening of prolapse which was noted right from the start.She had an anterior and posterior repair for a large cystocele and rectocele performed in (b)(6) 2015.She was doing well at the postoperative visit later in 2015.She was reviewed in (b)(6) 2016 when she was taking mirabegron and she had reasonable control.She came back to the clinic in 2018 with chronic pelvic and groin pain.She had a normal flexible cystoscopy under urology.She initially responded to depo-medrone and chirocaine injection but her symptoms recurred.On (b)(6) 2019, she had an excision of the left sided suprapubic aspect of the mesh from the skin down to the sheath.She was treated with some imipramine.She was seen by the local pain team on (b)(6) 2019.Repeat urodynamic tests on (b)(6) 2019 showed detrusor over activity.She had been using her pregabalin.Tolterodine 2 mg was advised to be taken with mirabegron and she was considered for intravesical botox treatment.She had her recurrent prolapse treated with an anterior repair with repeat injection of the depo-medrone and chirocaine in (b)(6) 2020.This helped with the prolapse.She had further input form the chronic pain team in (b)(6) 2020.Furthermore, she had a diagnosis of chronic fatigue syndrome/fibromyalgia and urgency.She gets the pain specifically in the morning when the bladder is full.She describes a hot sensation when the bladder is full.On (b)(6) 2022, the patient presented for an mri due to chronic right groin and suprapubic pain.Findings showed the mesh in its original place.No evidence of erosion, no collection or tape related complications.On (b)(6) 2022, the patient presented due to mesh complications as referred by her gynecologist.The mesh complications included: right pelvic pain and suprapubic pain.Main point was over scar.Worse in the morning.On bladder filling, walking, night and morning.Effect gait -- felt impacting right knee by over compensating.Still has some left groin pain.Recurrent utis.Managed locally.Luts (lower urinary tract symptoms).Stress urinary incontinence/urinary urgency.Incomplete emptying, associated with pain.Urge worse at night/morning.Plan: stay as is with pain/psychology support.Partial/vaginal mesh removal.Total mesh removal.On (b)(6) 2022, the patient had multidisciplinary review meeting.She was offered with pain and psychology assessments, referral to bariatric services and tgjtc in twelve months.Mdt outcomes: surgical plan.Pain management plan.Clinical psychology plan.Nursing plan.Imaging plan.Admin/managerial plan.Letter to patient and gp organized.Further mdt required.
 
Manufacturer Narrative
Patient identifier: as per eu gdpr (general data protection regulation), only the patient's weight, gender, and age can be reported in any regulatory report.Thus, the patient's initials and date of birth will not be documented.Date of event: the exact event onset date is unknown.The provided event date of september 1, 2015 was chosen as a best estimate based on the date of anterior and posterior repair.The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTAGE FIT SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15906263
MDR Text Key304726495
Report Number3005099803-2022-07173
Device Sequence Number1
Product Code OTN
UDI-Device Identifier08714729772880
UDI-Public08714729772880
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K020110
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/02/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM0068502110
Device Catalogue Number850-211
Was Device Available for Evaluation? No
Date Manufacturer Received11/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
Patient SexFemale
-
-